Biomaterial Database

Hyporeninaemic hypoaldosteronism after growth hormone treatment. 1996

H Mönig, and M Peter, and W G Sippell

UI	MeSH Term	Description	Entries
D006994	Hypoaldosteronism	A congenital or acquired condition of insufficient production of ALDOSTERONE by the ADRENAL CORTEX leading to diminished aldosterone-mediated synthesis of Na(+)-K(+)-EXCHANGING ATPASE in renal tubular cells. Clinical symptoms include HYPERKALEMIA, sodium-wasting, HYPOTENSION, and sometimes metabolic ACIDOSIS.	Acidosis, Renal Tubular Type IV,Hypoaldosteronism, Hyporeninemic,Renal Tubular Acidosis, Type IV,Type IV Renal Tubular Acidosis,Hyporeninemic Hypoaldosteronism
D012083	Renin	A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19.	Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D004392	Dwarfism	A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.	Nanism
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D000450	Aldosterone	A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.	Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D013006	Growth Hormone	A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized.	Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

H Mönig, and M Peter, and W G Sippell

Prostaglandins in hyporeninaemic hypoaldosteronism.

January 1978, Lancet (London, England),

H Mönig, and M Peter, and W G Sippell

Indomethacin-induced hyporeninaemic hypoaldosteronism.

April 1979, Lancet (London, England),

H Mönig, and M Peter, and W G Sippell

Hyporeninaemic hypoaldosteronism and systemic amyloidosis.

November 1995, Annals of clinical biochemistry,

H Mönig, and M Peter, and W G Sippell

Severe hyperkalaemia after cotrimoxazole administration in a patient with hyporeninaemic hypoaldosteronism.

June 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

H Mönig, and M Peter, and W G Sippell

Severe hyperkalaemia due to mefenamic acid-induced hyporeninaemic hypoaldosteronism.

January 1995, The British journal of clinical practice,

H Mönig, and M Peter, and W G Sippell

COVID-19 and late-onset hypertension with hyporeninaemic hypoaldosteronism.

January 2021, International journal of clinical practice,

H Mönig, and M Peter, and W G Sippell

Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism.

May 1984, Postgraduate medical journal,

H Mönig, and M Peter, and W G Sippell

Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism.

February 2007, The Netherlands journal of medicine,